Phytocompounds in the management of COVID-19: A review

被引:6
|
作者
Shamna, K. P. [1 ]
Arthanari, Malarvizhi [2 ]
Poyil, Muhammad Musthafa [3 ]
机构
[1] Deseeya Ayurved Pharmaceut Ltd, Calicut 673574, Kerala, India
[2] Vivekanandha Coll Arts & Sci Women, Dept Microbiol, Tiruchengode 637205, India
[3] Prince Sattam Bin Abdulaziz Univ, Coll Med, Dept Basic Med Sci, Al Kharj 11942, Saudi Arabia
来源
ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL | 2022年 / 11卷
关键词
COVID-19; Pandemic; Phytochemicals; Medicinal plants; DRUG DISCOVERY; SPIKE PROTEIN; CORONAVIRUS;
D O I
10.54085/ap.covid19.2022.11.3.5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rapid spread of coronavirus disease 19 (COVID-19) has forced the need for the discovery of new antiviral agent or the development of new vaccine to fight against the pandemic disease, COVID-19 or SARS-CoV-2 (severe acute respiratory syndrome corona virus-2), owing to its high mortality rate worldwide. Therefore, medicinal plants are gaining much attention for human health for the period of pandemic situation because of the efficient activity, cost effectiveness and limited side effects. These plants or phytochemicals have been used for several decades to treat various emerging virus infections through the inhibiting the various drug targets. Consequently, the current evidence indicating those medicinal plants or herbs and their component have the potent antiviral activity against SARS-CoV-2. Therefore, this review summarises the important Indian as well as Chinese medicinal plants and their phytochemicals or extracts which have the potency to battle with SARS-CoV-2 along with deciphered mechanism of action. These medicinal plants served as alternative treatment choice for the treatment of COVID-19 disease during this overwhelming pandemic situation.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [41] Is Covid-19 Sibling of SARS AND MERS? A Review on: Novel Covid-19
    Devi, Savita
    Singh, Kamaldeep
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2020, 54 (03) : 491 - 495
  • [42] Review about COVID-19
    Isam, Jameel Zahraa
    Kamil, Kadhim Zahraa
    Shaima, Banoon R.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (04): : 229 - 233
  • [43] Review of COVID-19 treatment
    Sadeghi, Somayeh
    Momenzadeh, Mahnaz
    Nasri, Peiman
    Nickpour, Mina
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2020, 9 (04) : 169 - 174
  • [44] Diabetes and COVID-19: A Review
    Baidya, Arjun
    Singh, Santosh Kumar
    Bajaj, Sarita
    Zargar, Abdul Hamid
    Singh, Parminder
    Das, Sambit
    Shankar, Anand
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2020, 35 (01): : 40 - 48
  • [45] COVID-19: AN UPDATED REVIEW
    Isihak, F. A.
    Hamad, M. A.
    Mustafa, N. G.
    INFEKTSIYA I IMMUNITET, 2020, 10 (02): : 247 - +
  • [46] COVID-19: Characteristics and Therapeutics
    Chilamakuri, Rameswari
    Agarwal, Saurabh
    CELLS, 2021, 10 (02) : 1 - 29
  • [47] COVID-19 and the eye: a review
    Armando Dominguez-Varela, Irving
    Alberto Rodriguez-Gutierrez, Luis
    Rubi Morales-Mancillas, Nallely
    Barrera-Sanchez, Maximiliano
    Macias-Rodriguez, Yolanda
    Eugenio Valdez-Garcia, Jorge
    INFECTIOUS DISEASES, 2021, 53 (06) : 399 - 403
  • [48] Organizations' Management of the COVID-19 Pandemic: A Scoping Review of Business Articles
    Boiral, Olivier
    Brotherton, Marie-Christine
    Rivaud, Leo
    Guillaumie, Laurence
    SUSTAINABILITY, 2021, 13 (07)
  • [49] Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review
    Madhu, Deepak
    Sharma, Sanchit
    Agarwal, Ashish
    Saraya, Anoop
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (04) : 568 - 575
  • [50] COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management
    Fraiman, Pedro
    Godeiro Junior, Clecio
    Moro, Elena
    Cavallieri, Francesco
    Zedde, Marialuisa
    FRONTIERS IN NEUROLOGY, 2020, 11